N. PAKSOY Et Al. , "Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors," Eurasian Journal of Medical Investigation , vol.6, no.3, pp.326-331, 2022
PAKSOY, N. Et Al. 2022. Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors. Eurasian Journal of Medical Investigation , vol.6, no.3 , 326-331.
PAKSOY, N., FERHATOĞLU, F., DOĞAN, İ., AK, N., PEHLİVAN, M., EKENEL, M., ... BAŞARAN, M.(2022). Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors. Eurasian Journal of Medical Investigation , vol.6, no.3, 326-331.
PAKSOY, NAİL Et Al. "Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors," Eurasian Journal of Medical Investigation , vol.6, no.3, 326-331, 2022
PAKSOY, NAİL Et Al. "Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors." Eurasian Journal of Medical Investigation , vol.6, no.3, pp.326-331, 2022
PAKSOY, N. Et Al. (2022) . "Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors." Eurasian Journal of Medical Investigation , vol.6, no.3, pp.326-331.
@article{article, author={NAİL PAKSOY Et Al. }, title={Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors}, journal={Eurasian Journal of Medical Investigation}, year=2022, pages={326-331} }